Compare AIRE & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AIRE | NTRB |
|---|---|---|
| Founded | 2021 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.2M | 71.7M |
| IPO Year | N/A | N/A |
| Metric | AIRE | NTRB |
|---|---|---|
| Price | $0.46 | $4.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $2.00 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 5.8M | 20.6K |
| Earning Date | 11-12-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,149,567.00 | $2,278,321.00 |
| Revenue This Year | $456.19 | $30.17 |
| Revenue Next Year | $105.16 | $3,394.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 994.18 | 12.69 |
| 52 Week Low | $0.14 | $3.72 |
| 52 Week High | $4.49 | $11.78 |
| Indicator | AIRE | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 43.60 | 45.40 |
| Support Level | $0.43 | $4.34 |
| Resistance Level | $0.60 | $4.77 |
| Average True Range (ATR) | 0.04 | 0.37 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 13.96 | 38.63 |
ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.